Építés alatt – nem éles oldal
Belépés

What researchers published on Zsírmáj (MASLD/MASH)

40 450 papers, newest first.

Showing 40 of 40 450

  • The prevalence of metabolic syndrome in patients with non-alcoholic fatty liver disease: Systematic review and meta-analysis of observational studies.Sage open chronic disease
  • ÁttekintésUltrasound quantification of liver fat in MASLD.European radiology
  • Human placenta extract declines fat deposition in an in vitro novel 3D MASLD model.In vitro models
  • Carbon Dots Derived from Carbonized Citri Reticulatae Pericarpium (Chenpi) Alleviate Metabolic Dysfunction-Associated Steatohepatitis.Molecules (Basel, Switzerland)
  • Reply to Khan and Shoro: Endoscopic ultrasound strain elastography in metabolic dysfunction-associated steatotic liver disease: Evaluation against transient elastography and non-invasive markers.Hepatology forum
  • Randomizált vizsgálatEffects of Whole "Navelina" Orange Consumption on Glucose Homeostasis and Fructosamine Levels in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Randomized Controlled Trial.Nutrients
  • ÁttekintésThe role and mechanisms of the vascular microenvironment in metabolic dysfunction- associated fatty liver disease.Frontiers in endocrinology
  • Early Metabolic and Cardiovascular Alterations in Adolescents with MASLD or Simple Obesity.Nutrients
  • Protective Effect of Palmitoleic Acid on Alcoholic Fatty Liver Injury in Mice: Insights from Gut Microbiota and Untargeted Metabolomics Analysis.Nutrients
  • Integrated Cardiovascular-Kidney-Metabolic Disease Burden in Mexico: Trends from 2000 to 2023 and Projections to 2050.Annals of global health
  • Growth Hormone Reduces Liver Tumor Development in a MASLD-Related HCC Murine Model.International journal of molecular sciences
  • Renal Multiparametric MRI for Early Detection and Longitudinal Monitoring of Metabolic Dysfunction Associated Steatotic Liver Disease Associated Kidney Injury: Histopathologic Validation and Multi-Omics Profiling.Journal of magnetic resonance imaging : JMRI
  • Clinical Advances in Metabolic Dysfunction-Associated Steatotic Liver Disease: Context, Measurement, and Treatment.Journal of clinical medicine
  • ÁttekintésNavigating MASLD heterogeneity: from metabolic risk to precision stratification.Frontiers in medicine
  • Gut microbiota dysbiosis and altered short-chain fatty acid biosynthetic pathways in Chinese children with obesity and nonalcoholic fatty liver disease.Frontiers in endocrinology
  • MetaanalízisSilymarin-Based Therapies in Chronic Liver Disease: A Systematic Review of Biochemical, Cardiometabolic, Steatosis, and Fibrosis-Related Outcomes.Nutrients
  • Network toxicology, molecular docking and in vitro validation reveal the molecular mechanisms of bisphenol A-induced MASLD.Frontiers in pharmacology
  • Circadian Rhythm-Related Characteristics and Adiposity in Relation to CAP-Defined Hepatic Steatosis Among Shift and Non-Shift Workers: A Pilot Study.Nutrients
  • Short- and Medium-Chain Fatty Acid Profiles in Biopsy-Proven Metabolic Dysfunction-Associated Steatotic Liver Disease: A Cross-Sectional Study.Nutrients
  • Chronic Consumption of Ghee (Clarified Butter) and Coconut Oil, but Not Palmolein, Induces Microvesicular Steatosis, Insulin Resistance, and Inflammation in Mice Fed a High-Fat Diet.Nutrients
  • Association Between Free Triiodothyronine and Metabolic Dysfunction-Associated Steatotic Liver Disease in Euthyroid Population: Evidence from NHANES 2007-2012.Healthcare (Basel, Switzerland)
  • Transcriptomic Profiling Identifies Hub Transcription Factors Associated with the Protective Effects of Licochalcone A Against HFD-Induced MASLD.Nutrients
  • Szisztematikus áttekintésUltra-Processed Food Consumption and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Evidence Synthesis, Methodological Appraisal, and Mechanistic Insights.Nutrients
  • ÁttekintésNutritional Impairment and Muscle Health in MASLD: The Potential Role of Eating Behaviors.Journal of clinical medicine
  • Multiparametric 0.4-T low-field MRI mapping for metabolic dysfunction-associated steatotic liver disease in rats.European radiology experimental
  • Altered Hepatic Hydrogen Sulfide-Related Homeostasis in Metabolic Dysfunction-Associated Steatotic Liver Disease and Its Changes Following Sleeve Gastrectomy.Journal of clinical medicine
  • ÁttekintésStatins and the Lifetime Outcomes of MASLD: From Evidence Asymmetry to Outcome Convergence.International journal of molecular sciences
  • Bacillus megaterium 1259 Limits Hepatic Lipid Accumulation in Mice with Established Diet-Induced Obesity: Paired Hepatic Transcriptomic and Metabolomic Profiling.Nutrients
  • MetaanalízisLarge-Scale Transcriptomic Meta-Analysis of Mouse Liver Responses to High-Fat Diet Identifies a Reproducible Core and Duration-Associated Variation.International journal of molecular sciences
  • ÁttekintésTrained Immunity and Persistent Myeloid Responsiveness in MASH.Cells
  • ÁttekintésMitochondrial Fatty Acid Oxidation Dysregulation in Metabolic Dysfunction-Associated Steatotic Liver Disease: Mechanistic Roles and Emerging Diagnostic and Therapeutic Advances.Pharmacological research
  • MRI-Derived Muscle Composition and Visceral Adiposity in Relation to Mortality and Vascular Outcomes in MASLD.Diagnostics (Basel, Switzerland)
  • Response to "Endoscopic ultrasound strain elastography in metabolic dysfunction-associated steatotic liver disease: Evaluation against transient elastography and non-invasive markers".Hepatology forum
  • Integrated chemical profiling and lipidomics reveal that Mailuoning oral liquid alleviates diet-induced MASLD via PPARα-mediated lipid homeostasis and COX-2 inhibition, with identification of potential active constituents.Frontiers in pharmacology
  • Low-intensity pulsed ultrasound ameliorates diet-induced MASLD with hepatic lipid metabolic remodeling.Biochimica et biophysica acta. Molecular basis of disease
  • Early Sugar Exposure and the Lifelong Prevention of MASLD.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • Association between systemic immune-inflammation index and skeletal muscle mass in patients with nonalcoholic fatty liver disease: A cross-sectional study.Medicine
  • Tubastatin A Mitigates Lipotoxicity, Inflammation and Fibrosis Through Downregulation of HDAC6 and Modulation of AMPK-FGF21 Axis in Metabolic Dysfunction-Associated Steatohepatitis.Inflammation
  • Metabolic Dysfunction-Associated Steatotic Liver Disease, With and Without Increased Alcohol Intake, and Incident Atrial Fibrillation in Older Korean Adults: A Competing-Risk Cohort Study.Geriatrics & gerontology international
  • Associations of metabolic dysfunction-associated steatotic liver disease and cardiometabolic burden with urinary tubular biomarker abnormalities: a cross-sectional health examination study.Frontiers in medicine